31.7 C
Delhi
Sunday, April 21, 2024

Tag: Cancer Portfolio

Merck Expands Colorectal Cancer Portfolio Through Licensing Agreement with Inspirna

Business Wire India First-in-class ompenaclid (RGX-202) currently in Phase II development for RAS-mutated advanced or metastatic colorectal cancer Collaboration includes exclusive license outside the...

- A word from our sponsors -

spot_img

Follow us

HomeTagsCancer Portfolio